209 |
2024/03 (Mar) |
HIRA vs. DAXX: the two axes shaping the histone H3.3 landscape |
947 |
208 |
2024/03 (Mar) |
Pathological phenotypes of astrocytes in Alzheimer’s disease |
935 |
207 |
2024/03 (Mar) |
Exploring the potential of Toxoplasma gondii as a drug development and delivery system |
906 |
206 |
2024/03 (Mar) |
Distinct characteristics of the DNA damage response in mammalian oocytes |
900 |
205 |
2024/03 (Mar) |
Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies |
887 |
204 |
2024/03 (Mar) |
Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer's disease |
821 |
203 |
2024/03 (Mar) |
Effects of fine particulate matter on bone marrow-conserved hematopoietic and mesenchymal stem cells: a systematic review |
886 |
202 |
2024/03 (Mar) |
Deciphering the molecular mechanisms of stem cell dynamics in hair follicle regeneration. |
924 |
201 |
2024/03 (Mar) |
4-1BB immunotherapy: advances and hurdles |
865 |
200 |
2024/03 (Mar) |
Microbial underdogs: exploring the significance of low-abundance commensals in host-microbe interactions |
852 |